Medicure MCUJF
OTC MCUJF
$1.95 +0.09 (+4.84%)
At close: Sep 28, 2026 · 4:00 PM EDT

Medicure (MCUJF) Gross Margin (2009 - 2026)

Updated

Medicure's Gross Margin came in at 43.06% for the quarter ended Jun 30, 2026, down 8.45 percentage points from 51.51% a year earlier and down 1.25 percentage points from the prior quarter.

Analysis

Medicure (MCUJF) Gross Margin (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Medicure reported Gross Margin of 38.02%, down 15.94 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 40.71%, down 19.03 percentage points from the prior year.

  • Gross Margin has declined in each of the last three years, with a five-year change of -3.47 percentage points (years ended Dec 2020 to Dec 2025).
  • Going back by year, Gross Margin was 59.75% in the year ended Dec 31, 2024 (-4.74 pp), 64.48% in the year ended Dec 31, 2023 (-5.21 pp), 69.69% in the year ended Dec 31, 2022 (+11.23 pp) and 58.46% in the year ended Dec 31, 2021 (+14.28 pp).
  • The five-year range for quarterly Gross Margin is 31.57% (the quarter ended Dec 31, 2025) to 73.69% (the quarter ended Sep 30, 2022).
  • Year-over-year, Gross Margin has declined for nine consecutive quarters, with an average year-over-year change of -14.31 percentage points over the last eight quarters.
  • The fastest year-over-year change in Gross Margin over five years came in the quarter ended Sep 30, 2022 (a gain of 15.10 percentage points), and the weakest in the quarter ended Dec 31, 2025 (a drop of 26.80 percentage points).
  • Business Quant data shows MCUJF's Gross Margin at 44.31% (quarter ended Mar 31, 2026), 31.57% (quarter ended Dec 31, 2025) and 33.99% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Medicure 203.51 Mn 195.32 Mn 2.31 Mn 43.06%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.06%
Mar 31, 2026 44.31%
Dec 31, 2025 31.57%
Sep 30, 2025 33.99%
Jun 30, 2025 51.51%
Mar 31, 2025 51.84%
Dec 31, 2024 58.37%
Sep 30, 2024 54.32%
Jun 30, 2024 57.15%
Mar 31, 2024 68.44%
Dec 31, 2023 69.03%
Sep 30, 2023 72.77%
Jun 30, 2023 69.88%
Mar 31, 2023 67.45%
Dec 31, 2022 69.03%
Sep 30, 2022 73.69%
Jun 30, 2022 66.03%
Mar 31, 2022 70.42%
Dec 31, 2021 55.59%
Sep 30, 2021 58.59%
API Access

Medicure Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=MCUJF&period=max&api_key=YOUR_API_KEY